The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Palpebral Fissure Height, Eye Redness, and Patient-reported Eye Appearance
Latest Information Update: 19 May 2023
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Blepharoptosis
- Focus Therapeutic Use
- 01 May 2023 Results assessing the effects of topical oxymetazoline 0.1% on eyelid position, eye redness, and patient-perceived eye appearance in patients without severe ptosis, published in the Journal of Plastic, Reconstructive and Aesthetic Surgery: JPRAS.
- 21 Apr 2023 Status changed from active, no longer recruiting to completed.
- 11 May 2022 Status changed from recruiting to active, no longer recruiting.